Casting And Splinting - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The casting and splinting market size is projected to be USD 3.36 billion in 2025, USD 3.59 billion in 2026, and reach USD 5.23 billion by 2031, growing at a CAGR of 7.81% from 2026 to 2031. This report is Segmented by Product Type (Casting Supplies & Equipment, and More), Material (Fiberglass/Synthetic Polyurethane, and More), Application (Fracture Management, and More), End-User (Hospitals, and More), Distribution Channel (Direct To Providers, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Casting And Splinting Market Trends and Insights

Aging-Related Fragility Fractures Sustaining Demand

Health systems are responding to sustained increases in fragility fractures by expanding non-operative pathways that emphasize conservative care for stable injuries in older adults. Wrist and forearm fractures in seniors often transition to casting and splinting when surgery is not indicated, reinforcing recurring demand for immobilization devices in outpatient and rehabilitation settings. Post-hip fracture care creates downstream need for protective orthoses and boots during recovery, extending immobilization use beyond the acute event. European payers have moved to standardize fast-track fracture clinics, a model that is diffusing to major Asian urban centers where geriatric cohorts are expanding. Heightened attention to prevention and care pathways for fragility events underscores continuous utilization of casting and splinting products within integrated musculoskeletal care. Ongoing WHO guidance on fragility fracture prevention and management continues to shape service models and resource allocation in orthopedic care.

Shift to Outpatient, ASC, and Urgent Care Workflows

The United States counted 12,294 ambulatory surgery centers by early 2025 with orthopedic services embedded across more than one third of sites, and outpatient settings handled the large majority of surgical procedures by that time. Payment policy alignment supports this shift as ASCs gain steady reimbursement updates that favor same-day discharge workflows and streamlined supply chains. Providers increasingly adopt lightweight, low-exotherm synthetic casting systems that cure quickly and support rapid ambulation within narrow observation windows. Inventory strategies favor prepackaged kits and dedicated SKUs that simplify ordering, storage, and coding, which raises mix toward higher-margin products. Workflow digitization further accelerates adoption, as platforms like MotionMD help tie specific immobilization SKUs to appropriate billing codes and documentation within the episode of care.

Regulatory Exposure to Diisocyanates in Polyurethanes

New EU exposure limits for monomeric diisocyanates in polyurethane processing introduce tighter controls on workplace air quality and handling procedures, prompting manufacturing reformulation and additional training obligations. Facilities must adapt ventilation, implement continuous monitoring, and refresh worker education on defined intervals as the limits phase into full enforcement. These requirements add costs that are harder to pass through for low-ASP, high-volume consumables, creating margin pressure on standard casting tapes. European suppliers are accelerating development of diisocyanate-free alternatives and moving to water-based dispersions, while advancing MDR certifications to preserve access in regulated tenders. Communication from industry publications has highlighted the harmonized exposure thresholds and timelines across the EU that are now shaping procurement and product design decisions.

Other drivers and restraints analyzed in the detailed report include:

• Digital/3D Scanning and Additive Manufacturing Enable Custom Immobilization
• Material Innovation Toward Lightweight Fiberglass and Thermoformable Systems
• Polymer and Logistics Volatility Impacting Input Costs

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Casting supplies and equipment held 55.23% of revenue in 2025 as clinicians adopt functional treatment where stability permits. Hospitals maintain steady utilization of rigid casts for displaced fractures and immediate post-operative stabilization, which anchors the installed base of casting tools and accessories. Splinting gains traction for ambulatory care pathways that require adjustability, hygiene, and faster return to light activity. Clinics also emphasize ergonomic cast cutters and dust extraction accessories to reduce particulate exposure during removal. The casting and splinting market continues to shift mix toward prepackaged splinting kits and color-coded materials that standardize workflows across high-volume sites.

Splinting supplies and equipment are projected to grow at 8.56% CAGR during 2026-2031. Prefabricated fiberglass and thermoplastic splints capture a leading share within splinting due to ease of application and lower setup times in outpatient and urgent care clinics. Night splints for common repetitive strain conditions benefit from coverage policies that support home use and remote guidance. Malleable aluminum foam splints retain a role in emergency medical kits where simplicity and reusability matter. The casting and splinting market aligns product design with coding and documentation tools that help providers secure appropriate reimbursement for each immobilization episode. As functional bracing philosophies diffuse, the product mix within the casting and splinting market favors removable systems that maintain protection while enabling monitored motion.

Fiberglass or synthetic polyurethane accounted for 45.15% of revenue in 2025. A January 2024 article in BMC Musculoskeletal Disorders highlighted a groundbreaking biobased polyester cast. This innovative cast not only matches the stability of traditional fiberglass casts but also enhances patient satisfaction, all while being more eco-friendly and safer. In the study, 100 patients were randomly assigned via sealed envelopes to one of two groups: the biobased polyester cast group (using MEDlite Thermo Casting Tape from Taipei Smart Materials, Taipei, Taiwan) or the fiberglass cast group (utilizing Scotchcast from 3M Health Care, Maplewood, Minnesota, U.S.). Each group comprised 50 patients. Traditional synthetic casts often contain harmful components such as isocyanates, which can lead to skin issues, including itching, redness, and dryness. This novel biobased cast is crafted from a newly developed, nontoxic, and biodegradable copolymer. This copolymer, named poly(ethylene sebacate-co-ethylene adipate) (PESA), is synthesized from the green resource sebacic acid and is copolymerized with ethylene glycol, trimesic acid, aminocaproic acid, and adipic acid. Notably, animal studies have indicated that skin exposure to such chemical allergens can trigger asthmatic responses.

Low-temperature thermoplastics are the fastest-growing material at an 8.65% CAGR for 2026-2031 due to chairside remoldability. Thermoplastics soften in warm-water or controlled-heat setups and allow clinicians to fine-tune fit without complete reapplication. In regions with sustainability mandates, qualified bio-based thermoplastic formulations have begun to appear in non-load-bearing devices, supported by molder certifications and hospital procurement criteria. Polyester-based tapes with low-tack resins emphasize lower dust during saw removal and improved radiolucency, which is valued in pediatric follow-up imaging. The casting and splinting market shows ongoing preference for materials that reduce skin complications, odor, and maceration, while maintaining adequate rigidity in daily wear.

Plaster of Paris remains relevant for budget-constrained settings where acquisition cost and supply simplicity guide product selection. Aluminum splints serve specialized use cases that benefit from reusability and quick field application. Thermoplastic adoption gains momentum in markets where regulation around diisocyanates encourages alternatives and where clinics invest in small-form heating equipment. The casting and splinting market accommodates both incumbent fiberglass tapes and expanding thermoplastic lines, as buyers weigh per-roll cost against adjustability, patient comfort, and clinic throughput. As suppliers roll out next-generation composites and antimicrobial additives, material choice continues to diversify, which sustains competitive differentiation.

Complete Report Scope:

• By Product Type
  • Casting supplies & equipment
    • Casting tapes
    • Plaster casts
    • Cast cutters
    • Tools & accessories
  • Splinting supplies & equipment
    • Prefabricated fiberglass/plaster
    • Thermoplastic sheets/rolls
    • Aluminum foam
    • Night splints
• By Material
  • Fiberglass/synthetic polyurethane
  • Plaster of Paris
  • Thermoplastic (low-temp)
  • Polyester fabric
  • Aluminum (splints)
• By Application
  • Fracture management
    • Upper extremity
    • Lower extremity
  • Acute sprains and strains
  • Postoperative immobilization
  • Pediatric fracture care
  • Sports injuries
• By End-User
  • Hospitals
  • Orthopedic & trauma clinics
  • Ambulatory surgery centers
  • Rehab/OT/PT clinics
  • Home care
• By Distribution Channel
  • Direct to providers
  • Distributor/Dealer
  • E-commerce
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 45.64% of revenue in 2025 on the strength of outpatient alignment, broad ASC penetration, and fast adoption of premium immobilization technologies that secure coverage under value-based care. The region’s outpatient infrastructure rests on 12,294 ASCs in the United States by 2025 and a high share of procedures performed outside inpatient settings, which channel fracture care toward same-day stabilization options. Providers deploy custom 3D-printed splints and water-friendly liner systems to improve comfort and adherence in pediatric and adult cases. Clinic and ASC focus on speed supports uptake of low-exotherm synthetics that set quickly, enabling discharge within short observation windows. Regional consolidation among hospitals has shifted some trauma volumes while intensifying emphasis on inventory automation and coding accuracy to defend margins. Changes in professional sport injury profiles during 2025 illustrate how safety policy can influence case mix, with some lower-extremity injuries reduced under updated rules. The casting and splinting market in North America continues to emphasize supply reliability, patient comfort, and clean documentation across ambulatory pathways.

Asia-Pacific is projected to grow at an 8.31% CAGR over 2026-2031 as urbanization raises trauma incidence and as universal coverage programs expand access to stabilization beyond tertiary hubs. China’s aging cohort accelerates fragility volumes, while India and Southeast Asia advance district-level access to fracture care through broader funding and referral networks. Pilots of pediatric 3D-printed splints in leading Japanese centers have reported favorable functional outcomes, reinforcing premium-tier interest where clinical acceptance aligns with customization benefits. Government support in select markets has aimed to stabilize petrochemical inputs and ensure consistent availability of resins necessary for casting tapes. In lower-resource environments across the broader region, plaster maintains a role due to cost and supply continuity, while fiberglass adoption rises with improvements in distribution. The casting and splinting market balances product portfolios across APAC to reflect both premium customization and volume-led consumables.

Europe faces dual pressures from regulatory changes and trade frictions that influence material selection and export dynamics for suppliers. New EU diisocyanate exposure limits require investments in compliance, catalyze resin reformulations, and influence tender specifications that shape product choice for casting tapes. Import tariffs on medical devices in some export markets since 2025 have nudged suppliers to adjust logistics routes or rebalance production footprints to mitigate cost exposure. In France, reimbursement policies sustain use of removable splints for common ankle injuries encountered over a lifetime, maintaining steady demand for functional solutions. Spain and Italy continue to rely on public-tender formularies that reward lowest unit costs, which preserves a role for plaster alongside lighter synthetics. European suppliers emphasize MDR certifications and sustainability credentials as differentiators while extending digital portals to streamline ordering and training for hospitals and clinics. The casting and splinting market in Europe reflects a balance of compliance-driven product evolution and steady utilization in high-volume trauma and orthopedic pathways.

List of Companies Covered in this Report:

• Breg (FastForm)
• DeRoyal Industries
• Dynatronics/Bird & Cronin
• Enovis/DJO (Exos, Aircast, ProCare)
• Essity (Delta-Cast, Ortho-Glass)
• Henry Schein (ECA casting tape)
• Lohmann & Rauscher (Cellona, padding)
• Medline Industries
• Orfit Industries
• Performance Health (Rolyan)
• SAM Medical (SAM Splint)
• Solventum (3M Health Care, Scotchcast)
• Stryker (Cast removal systems)
• Tynor Orthotics
• United Ortho

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support